Related by context. Frequent words. (Click for all words.) 70 VEGFR2 inhibitor 70 MKC# 68 hepatitis C lupus 67 CDAD Clostridium difficile 67 sorafenib tablets 67 Initiates Phase II 67 refractory chronic lymphocytic 66 R sorafenib tablets 66 oncolytic virus therapies 66 YOUR LOCAL ANIMAL SHELTER 66 Completes Patient Enrollment 65 Initiate Phase 65 Panzem R 65 Drug Shows Promise 64 Sapacitabine 64 inflammatory autoimmune diseases 64 Phase Ib IIa 64 Meets Primary Endpoint 64 Romidepsin 64 Belimumab 64 Pivotal Phase 64 forodesine 63 ® bortezomib 63 Daclizumab 63 trastuzumab DM1 T DM1 62 gets USFDA nod 62 Mipomersen 62 Commences Phase 62 2 methoxyestradiol 62 Saxagliptin 62 rheumatoid arthritis psoriasis 62 PSMA ADC 62 autoimmune disorders asthma 62 GSK# [002] 62 Major Depressive Disorder MDD 62 Metastatic Melanoma 61 Receives Orphan Drug Designation 61 Fabry Disease 61 Phase Ib II 61 TTR amyloidosis 61 Drug Candidate 61 Pivotal Phase III 61 advanced carcinoid 61 Prodarsan ® 61 Dapagliflozin 61 rheumatoid arthritis psoriatic arthritis 61 TRACON Pharmaceuticals Inc. 61 Panzem R NCD 61 Clinical Trial Results 61 gastrointestinal mucositis 61 CDP# 61 Nexavar ® 61 Patient Registries 61 FDA Accepts 61 Imetelstat 61 oral deforolimus 61 Rotavirus Vaccine 61 ZFP Therapeutics 61 Diamyd ® 60 Tesetaxel 60 interferon gamma 1b 60 thetreatment 60 phase IIb clinical 60 Laquinimod 60 Presents Positive 60 Cetrorelix 60 Inhalation Aerosol 60 Canvaxin 60 treat nicotine addiction 60 Darinaparsin 60 elotuzumab 60 non personalized allogeneic 60 fostamatinib 60 Golimumab 60 Plicera 60 TRAIL receptor antibodies 60 Completes Enrollment 60 Fast Track Status 60 Initiates Phase 60 Lennox Gastaut syndrome 60 Unit Dose Budesonide 60 Vandetanib 60 Genz # 60 TELINTRA 60 Single Dose 60 opioid induced bowel dysfunction 60 Study Evaluating 60 liver cancers hypercholesterolemia 60 Pirfenidone 60 Renal Cell Carcinoma 59 Phase III Clinical Trial 59 GVAX R 59 GLPG# 59 oral antiviral 59 Cutaneous T 59 Melphalan 59 senicapoc 59 Motavizumab 59 Dasatinib 59 INCB# [001] 59 here http:/blogs.nashuatelegraph.com/webnotes/#Culminating